Corporate profile
Qilian International Holding Group Limited, a Cayman Islands holding company, operates through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. and its affiliates, with a rich history dating back to 1969. We specialize in bio-fermentation, bio-extraction, and pharmaceutical formulation, leveraging over 50 years of production expertise to serve the global pharmaceutical industry.
Events
Qilian International Holding Group Limited Anounces Name Change to BGM Group Ltd.
In a strategic move to embrace a more open and inclusive development in the pharmaceutical and healthcare sector, our company has decided to change its group […]
Our Trading Ticker Symbol has Changed to “BGM”
Effective August 11, 2024, our company’s trading ticker symbol has been updated from “QLI” to “BGM”. For more details, visit our news release at PR Newswire.Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split
Qilian International Holding Group Limited (NASDAQ: QLI) has received board approval for a 1 for 5 reverse stock split, set to take effect on June 21, […]
Qilian International Holding Group Ltd Announces Leadership and Board Changes to Drive Forward Growth and Innovation
Qilian International Holding Group Ltd has announced major leadership and board changes, including the appointment of new CEO and CFO, along with the addition of two […]